Brain neurodegenerative diseases (BND) are debilitating conditions that are especially characteristic of a certain period of life and considered major threats to human health …
M Wang, M Wang, J Zhao, H Xu, Y Xi, H Yang - Phytomedicine, 2023 - Elsevier
Background Cardiac fibrosis contributes to myocardial remodeling after myocardial infarction (MI), which may facilitate the progression to end-stage heart failure. Dengzhan …
M Khalid Danish, JP Gleeson, DJ Brayden… - International journal of …, 2022 - mdpi.com
Isoleucine-Proline-Proline (IPP) and Leucine-Lysine-Proline (LKP) are food-derived tripeptides whose antihypertensive functions have been demonstrated in hypertensive rat …
The advancement in the processing speeds of computing machines has facilitated the development of complex physiologically based pharmacokinetic (PBPK) models. These …
LA Torpet, C Kragelund, J Reibel… - Critical reviews in oral …, 2004 - journals.sagepub.com
A great many cardiovascular drugs (CVDs) have the potential to induce adverse reactions in the mouth. The prevalence of such reactions is not known, however, since many are …
LM Godsel, JS Leon, K Wang, JL Fornek… - The Journal of …, 2003 - journals.aai.org
Captopril, an angiotensin-converting enzyme inhibitor, is widely used in the treatment of a variety of cardiomyopathies, but its effect on autoimmune myocarditis has not been …
An increasing problem in the field of health protection is the emergence of drug-resistant and multi-drug-resistant bacterial strains. They cause a number of infections, including …
K Tsuda - International journal of hypertension, 2012 - Wiley Online Library
Many Studies suggest that changes in sympathetic nerve activity in the central nervous system might have a crucial role in blood pressure control. The present paper discusses …
TJ Bahk, MD Daniels, JS Leon, K Wang… - International journal of …, 2008 - Elsevier
The angiotensin converting enzyme inhibitor captopril prevents myosin-induced experimental autoimmune myocarditis. Captopril inhibits production of angiotensin II and …